Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid to reduce seroma formation after mastectomy
2020-005592-12Phase 4Terminated
- Sponsor
- Region Sjælland
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tranexamic acid in breast cancer and Seroma, sponsored by Region Sjælland. Primary endpoint: Postoperative seroma formation. Started Mar 2021; status: terminated.
02
Drugs
tranexamic acid
03
Conditions
breast cancerSeroma
Beyond the preview
Go deeper on 2020-005592-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005592-12.